Format

Send to

Choose Destination
JAMA Intern Med. 2018 Jan 1;178(1):5-6. doi: 10.1001/jamainternmed.2017.6145.

The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics.

Author information

1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
2
Solomon Center for Health Law and Policy, Yale Law School, New Haven, Connecticut.
3
Harvard Health Publishing, Harvard Medical School, Boston, Massachusetts.
4
Health Care Policy and Law Editor.

Erratum in

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center